&Partners’s C.H. Robinson CHRW Stock Holding History

&Partners’s Portfolio CHRW Stock Details CHRW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.55M	Buy	9,290 +7,054	+315%	+$1.26M	0.01%	1048
2025 Q4	$359K	Buy	+2,236	New	+$330K	﹤0.01%	1804

Other funds holding CHRW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

&Partners's CHRW Position: Q1 2026 in Review

&Partners increased its C.H. Robinson (CHRW) stake by 315% in Q1 2026, buying an estimated $1.26M and bringing the position to 9,290 shares worth $1.55M. The position accounts for 0.01% of the portfolio, ranked #1048.

&Partners first reported a position in CHRW in Q4 2025 and has held it in 2 quarters since. 883 funds tracked by Wall St. Rank hold CHRW as of Q1 2026.

&Partners held 9,290 shares of C.H. Robinson worth $1.55M as of Q1 2026.
&Partners bought 7,054 C.H. Robinson shares in Q1 2026, an estimated $1.26M.
C.H. Robinson made up 0.01% of &Partners's portfolio in Q1 2026, its #1048 holding.
&Partners first reported a position in C.H. Robinson in Q4 2025 and has held it in 2 quarters since.
883 funds tracked by Wall St. Rank held C.H. Robinson as of Q1 2026.

Based on &Partners's 13F filing for Q1 2026, filed 15 May 2026.